Given that NETs and anticardiolipin (aCL) have been independently found to be associated with the occurrence of thrombosis in various diseases, our study concurrently assessed NET markers, cirDNA, and aCL levels, to investigate their association and their potential as COVID‐19 biomarkers. This evidence concerns the gene ACLY and deep vein thrombosis.